Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Chromatinopathies: A focus on Cornelia de Lange syndrome

Laura Avagliano*, Ilaria Parenti, Paolo Grazioli, Elisabetta Di Fede, Chiara Parodi, Milena Mariani, Frank J. Kaiser, Angelo Selicorni, Cristina Gervasini, Valentina Massa

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

In recent years, many genes have been associated with chromatinopathies classified as “Cornelia de Lange Syndrome-like.” It is known that the phenotype of these patients becomes less recognizable, overlapping to features characteristic of other syndromes caused by genetic variants affecting different regulators of chromatin structure and function. Therefore, Cornelia de Lange syndrome diagnosis might be arduous due to the seldom discordance between unexpected molecular diagnosis and clinical evaluation. Here, we review the molecular features of Cornelia de Lange syndrome, supporting the hypothesis that “CdLS-like syndromes” are part of a larger “rare disease family” sharing multiple clinical features and common disrupted molecular pathways.

OriginalspracheEnglisch
ZeitschriftClinical Genetics
Jahrgang97
Ausgabenummer1
Seiten (von - bis)3-11
Seitenumfang9
ISSN0009-9163
DOIs
PublikationsstatusVeröffentlicht - 01.01.2020

Fördermittel

The authors are grateful to the following fundings: Fondazione Cariplo (2015‐0783 to V.M.); Dipartimento DISS, Linea 2, Università degli Studi di Milano (to C.G. and V.M.); Molecular and Translational Medicine PhD—Università degli Studi di Milano scholarship (to P.G.); Translational Medicine PhD—Università degli Studi di Milano scholarship (to C.P.); Nickel & Co S.p.A; Medical Faculty of the University of Lübeck (J09‐2017 to I.P.); German Federal Ministry of Education and Research (BMBF) (CHROMATIN‐Net to F.J.K.). The authors would also like to thank the Italian National Association of Volunteers Cornelia de Lange for support and inspiration and Susanna Brusa for graphical support.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

  • Querschnittsbereich: Medizinische Genetik

Fingerprint

Untersuchen Sie die Forschungsthemen von „Chromatinopathies: A focus on Cornelia de Lange syndrome“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren